Latest study has demonstrated that the NFκB pathway can be initiated to promote proinflammatory cytokine expression in periodontitis [64]; in particular, NFκB can be activated in hPDLSCs treated with LPS-G [65]. This evidence concerns the gene NFKB1 and periodontitis.